Peptide library Growth-Hormone Axis

Tesamorelin

Also known as: Stabilised GHRH analogue

A GHRH analogue studied for growth-hormone signalling and visceral-fat reduction in defined research settings.

Visceral fat
GHRH receptor
Lipid markers

What it is

Plain-English overview

Tesamorelin is a stabilised full-length GHRH analogue. Among growth-hormone-axis peptides, it stands out for formal study around visceral adipose tissue.

Mechanism

How it is thought to work

It prompts the pituitary to release growth hormone, increasing downstream IGF-1 and influencing fat metabolism. The key research target is deep abdominal fat around the organs.

Studied for

Research interest areas

Visceral abdominal fat
Body composition
Metabolic markers

Evidence

What the research suggests

Controlled human trials in specific clinical populations reported reductions in visceral fat. General wellness use is a separate question and needs medical context.

A note on safety. This content is educational and is not medical advice. Many peptides and adjacent compounds are research materials and may not be approved medicines. Speak with a qualified healthcare professional before considering anything discussed here.